Search Results 641-650 of 19249 for Hemoglobin

  1. RLY-2608-201-Ph2 Study Of RLY-2608 In PROS And PIK3CA Driven Malformations - Mayo Clinic

    Hemoglobin ≥ 9 g/dL (red blood cell transfusion and erythropoietin may be used to reach 9 g/dL but must have been administered at least 2 weeks prior to ...

  2. Benzocaine (oral route, oromucosal route) - Side effects & dosage - Mayo Clinic

    Hereditary metabolic disorder affecting red blood cells (eg, G6PD deficiency, hemoglobin-M disease, NADH-methemoglobin reductase deficiency, pyruvate-kinase ...

  3. Study of Magrolimab Combination Therapy to Treat Unresectable, Locally Advanced or Metastatic Triple-Negative Breast Cancer - Mayo Clinic

    hemoglobin inclusion criteria. - History of hemolytic anemia, autoimmune thrombocytopenia, or Evans syndrome in the last 3 months. - Prior treatment with ...

  4. Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer - Mayo Clinic

    Hemoglobin ≥ 9 g/dL (9 g/dL is equivalent to 90 g/L and 5.59 mmol/L). Hepatic: Total bilirubin ≤ 1.5 x the institutional upper limit of normal (ULN). For ...

  5. Dose-Escalated Photon IMRT or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma - Mayo Clinic

    Hemoglobin ≥ 10.0 g/dl (note: the use of transfusion or other intervention to achieve hemoglobin (Hgb) ≥ 10.0 g/dl is acceptable); Bilirubin ≤ 1.5 upper ...

  6. Ravulizumab in Immunoglobulin A Nephropathy (IgAN) - Mayo Clinic

    * Uncontrolled diabetes mellitus with glycosylated hemoglobin (HbA1c) \> 8.5%. * Clinically active Henoch-Schonlein purpura (IgA vasculitis) requiring ...

  7. A Study Of Ex Vivo Expansion (ACT-X) - Mayo Clinic

    The following laboratory values obtained ≤ 28 days prior to registration. Hemoglobin ≥910.0 g/dl. Absolute neutrophil count (ANC) ≥1500/mm3. Platelet count ...

  8. A Study of the Effect of Dalcetrapib on Cardiovascular Risk for a Genetically Defined Population who have had a Recent Acute Coronary Syndrome Event - Mayo Clinic

    Last known hemoglobin <10 g/dL; Index ACS event presumed due to uncontrolled hypertension. Participating Mayo Clinic locations. Study statuses change often ...

  9. A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ - Mayo Clinic

    * Hemoglobin \>= 9.0 g/dL (less than or equal to 28 days prior to registration) * Creatinine =\< 2 x upper limit of normal (ULN) (less than or equal to 28 ...

  10. Auranofin and Sirolimus in Treating Participants With Ovarian Cancer - Mayo Clinic

    Obtained =< 14 days prior to registration: Hemoglobin (Hgb) >= 9 g/dL; Obtained =< 14 days prior to registration: Total bilirubin =< 1.5 x upper limit of ...